NASDAQ Framework: R1 RCM Inc.
Healthcare IT firm specializing in revenue cycle management 1.
1: R1 RCM Inc. is an American 'revenue cycle management' company servicing hospitals, health systems and physician groups across the United States.RCM is the process of managing all revenue-generation functions in a healthcare organization. It requires an understanding of the revenue cycle and begins when a patient seeks the organization's medical services and ends when the organization has collected all payments from the patient and/or their insurer. R1 has over 1,000 clients across the United States, including hospitals, health systems, and physician groups. R1 RCM employs more than 27,200 people and generates approximately $2.1 billion in annual revenue. View Source
R1 RCM Inc. is an American revenue cycle management company that provides technology-driven solutions aimed at transforming the patient experience and financial performance of healthcare providers. Founded in 2003 as Accretive Health and rebranded in 2017, R1 RCM services hospitals, health systems, and physician groups across the United States. The company employs more than 27,200 people and generates approximately $2.1 billion in annual revenue 234.
2: R1 RCM Inc. is an American 'revenue cycle management' company servicing hospitals, health systems and physician groups across the United States.RCM is the process of managing all revenue-generation functions in a healthcare organization. It requires an understanding of the revenue cycle and begins when a patient seeks the organization's medical services and ends when the organization has collected all payments from the patient and/or their insurer. R1 has over 1,000 clients across the United States, including hospitals, health systems, and physician groups. R1 RCM employs more than 27,200 people and generates approximately $2.1 billion in annual revenue. View Source3: R1 RCM was founded as Accretive Health in 2003 by Mary Tolan and Michael Cline. Tolan served as the company's president, chief executive officer, and board director until 2013. Cline served as board chairman between 2009 and 2013.[1] View Source4: In 2017, Accretive Health was renamed as R1 RCM.[14] View Source
NO
R1 RCM Inc. was founded as Accretive Health in 2003 by Mary Tolan and Michael Cline. However, Mary Tolan served as the company's president, chief executive officer, and board director until 2013, and Michael Cline served as board chairman between 2009 and 2013 5. This indicates that the founders are no longer leading or heavily involved in the company.
R1 RCM Inc. was founded as Accretive Health in 2003 by Mary Tolan and Michael Cline. However, Mary Tolan served as the company's president, chief executive officer, and board director until 2013, and Michael Cline served as board chairman between 2009 and 2013 5. This indicates that the founders are no longer leading or heavily involved in the company.
5: R1 RCM was founded as Accretive Health in 2003 by Mary Tolan and Michael Cline. Tolan served as the company's president, chief executive officer, and board director until 2013. Cline served as board chairman between 2009 and 2013.[1] View Source
MEDIUM RISK
R1 RCM Inc. demonstrates a mixed financial situation. On one hand, the company has shown revenue growth, achieving a 10.69% increase as of March 31, 2024 6. However, it faces challenges in profitability with a net margin of -5.81% 7 and a return on assets (ROA) of -0.65% 8. Additionally, the company has a debt-to-equity ratio of 0.85, indicating a relatively conservative financial approach 9. The ongoing acquisition interest and strategic alternatives being evaluated also add a layer of uncertainty to its financial stability 1011. Therefore, while R1 RCM has potential for growth, its current financial metrics and external uncertainties place it in the medium risk category.
R1 RCM Inc. demonstrates a mixed financial situation. On one hand, the company has shown revenue growth, achieving a 10.69% increase as of March 31, 2024 6. However, it faces challenges in profitability with a net margin of -5.81% 7 and a return on assets (ROA) of -0.65% 8. Additionally, the company has a debt-to-equity ratio of 0.85, indicating a relatively conservative financial approach 9. The ongoing acquisition interest and strategic alternatives being evaluated also add a layer of uncertainty to its financial stability 1011. Therefore, while R1 RCM has potential for growth, its current financial metrics and external uncertainties place it in the medium risk category.
6: Revenue Growth: Over the 3 months period, R1 RCM showcased positive performance, achieving a revenue growth rate of 10.69% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector. View Source7: Net Margin: R1 RCM's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -5.81%, the company may face hurdles in effective cost management. View Source8: Return on Assets (ROA): R1 RCM's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.65%, the company may encounter challenges in delivering satisfactory returns from its assets. View Source9: Debt Management: R1 RCM's debt-to-equity ratio is below the industry average at 0.85, reflecting a lower dependency on debt financing and a more conservative financial approach. View Source10: R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives Sets Final Bid Deadline of July 31, 2024MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested par GlobeNewswire • 10 hours ago RCM -2.08% TowerBrook, CD&R in Advanced Talks to Make Offer for Health IT Firm R1 RCM (Bloomberg) -- TowerBrook Capital Partners has teamed up with Clayton, Dubilier & Rice to make a joint offer for R1 RCM Inc. that could kick off a bidding war for the health-care IT company.Most Read from BloombergBiden Exits Race, Endorses Harris as She Shores Up SupportBiden Is Out: What’s Next for Democrats, ExplainedBiden’s Exit Puts Trump Trade in Doubt as Election Gets Re-SetTrump’s Remarks Spark Rebuke From Mexico’s President-ElectWho Gets the $96 Million Sitting in Biden’s Campaign Accou Bloomberg • 5 days ago RCM -2.08% TowerBrook, CD&R Consider Joining Forces to Bid for R1 RCM (Bloomberg) -- TowerBrook Capital Partners and Clayton, Dubilier & Rice are in talks to team up and launch a rival takeover bid for health-care IT provider R1 RCM Inc., people familiar with the matter said.Most Read from BloombergZuckerberg Calls Trump’s Response to Shooting ‘Badass’From ATMs to Flights, Epic IT Crash Leaves Trail of ChaosCrowdStrike’s Global Outage Doesn’t Have to Be a Recurring NightmareTravel Chaos Mounts as Airlines Resume Flights After OutageBiden Vows Return to Campaign Tr Bloomberg • 5 days ago RCM -2.08% Merger-Arb Traders Bet on a Few Deals After Ugly Start of Year (Bloomberg) -- Merger-arbitrage investors are betting on just a small handful of deals in the third quarter, including potential acquisitions of R1 RCM Inc. and Macy’s Inc., after a rough start to the year, with regulatory, legal and political hurdles delaying or outright quashing big deals.Most Read from BloombergLSE Joins Banks, Airlines in Cascade of Global DisruptionsCanada’s Immigration Minister Has a Message for Foreign Students: You Can’t All StayBrookfield Lines Up a 36-Year-Old Rising S Bloomberg • 6 days ago RCM -2.08% R1 RCM to Release Second Quarter 2024 Results on August 7, 2024 MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confer GlobeNewswire • 9 days ago RCM -2.08% New Mountain offers to acquire healthcare services provider R1 RCM New Mountain aims to purchase all of R1 RCM’s outstanding shares that it does not already own for $13.25 each. Hospital Management • 20 days ago RCM -2.08% Stocks to Watch Tuesday: Tesla, Chewy, Nvidia **↗️** **Tesla (TSLA)**: The electric-vehicle maker's shares rose roughly 9% after the company's second-quarter vehicle deliveries, a proxy for sales, fell by less than expected. Shares of smaller EV company **Rivian (RIVN)** also rallied. The Wall Street Journal • 22 days ago RCM -2.08% ERFSF TSLA R1 RCM to Host a Virtual Event “Technology Teach-In: A Deep Dive into Key Focus Areas and the R1 Platform” on June 27, 2024 MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. The event will feature Steve Albert, Executive Vice President and Chief Product Officer, and Brian Gambs, Executive Vice President and Chief Technolo GlobeNewswire • last month RCM -2.08% R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webc GlobeNewswire • last month RCM -2.08% R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Call Transcript R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Call Transcript May 8, 2024 R1 RCM Inc. misses on earnings expectations. Reported EPS is $-0.08349 EPS, expectations were $-0.05. R1 RCM Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […] Insider Monkey • 2 months ago RCM -2.08% R1 RCM Inc (RCM) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with Robust ... Despite facing operational disruptions, R1 RCM Inc (RCM) reports a strong financial performance and proactive crisis management in the first quarter of 2024. GuruFocus.com • 2 months ago RCM -2.08% Compared to Estimates, R1 RCM INC (RCM) Q1 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for R1 RCM INC (RCM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Zacks • 2 months ago RCM -2.08% R1 RCM Inc. (RCM) Q1 2024 Earnings: Revenue Surpasses Estimates Despite Net Loss Detailed Analysis of First Quarter Financials and Updated Outlook GuruFocus.com • 2 months ago RCM -2.08% R1 RCM Reports First Quarter 2024 Results MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss GlobeNewswire • 2 months ago RCM -2.08% R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Bank of America Securities Health Care Conference on Thursday, May 16, 2024, at 11:00am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay GlobeNewswire • 2 months ago RCM -2.08% 10 Best Healthcare Stocks to Buy Under $20 In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthcare Outlook for 2024 As 2024 progresses, the optimism surrounding the healthcare […] Insider Monkey • 3 months ago RCM -2.08% NVST +0.25% OSCR R1 RCM to Release First Quarter 2024 Results on May 8, 2024 MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confere GlobeNewswire • 3 months ago RCM -2.08% R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprintMURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company’s commitment to improving access to healthcare, bringing GlobeNewswire • 3 months ago RCM -2.08% R1 RCM Forms Special Committee to Evaluate Strategic Alternatives MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the GlobeNewswire • 4 months ago RCM -2.08% What Makes R1 RCM (RCM) a Lucrative Investment? Voss Capital, LLC an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned 19.4% and 18.6% net of fees and expenses respectively, in the fourth quarter compared to a 14.0% return for the […] Insider Monkey • 4 months ago RCM -2.08% ^RUT View Source11: MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to submit fully-financed bids on July 31, 2024 in connection with its review process. View Source
12: R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives Sets Final Bid Deadline of July 31, 2024MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested par GlobeNewswire • 10 hours ago RCM -2.08% TowerBrook, CD&R in Advanced Talks to Make Offer for Health IT Firm R1 RCM (Bloomberg) -- TowerBrook Capital Partners has teamed up with Clayton, Dubilier & Rice to make a joint offer for R1 RCM Inc. that could kick off a bidding war for the health-care IT company.Most Read from BloombergBiden Exits Race, Endorses Harris as She Shores Up SupportBiden Is Out: What’s Next for Democrats, ExplainedBiden’s Exit Puts Trump Trade in Doubt as Election Gets Re-SetTrump’s Remarks Spark Rebuke From Mexico’s President-ElectWho Gets the $96 Million Sitting in Biden’s Campaign Accou Bloomberg • 5 days ago RCM -2.08% TowerBrook, CD&R Consider Joining Forces to Bid for R1 RCM (Bloomberg) -- TowerBrook Capital Partners and Clayton, Dubilier & Rice are in talks to team up and launch a rival takeover bid for health-care IT provider R1 RCM Inc., people familiar with the matter said.Most Read from BloombergZuckerberg Calls Trump’s Response to Shooting ‘Badass’From ATMs to Flights, Epic IT Crash Leaves Trail of ChaosCrowdStrike’s Global Outage Doesn’t Have to Be a Recurring NightmareTravel Chaos Mounts as Airlines Resume Flights After OutageBiden Vows Return to Campaign Tr Bloomberg • 5 days ago RCM -2.08% Merger-Arb Traders Bet on a Few Deals After Ugly Start of Year (Bloomberg) -- Merger-arbitrage investors are betting on just a small handful of deals in the third quarter, including potential acquisitions of R1 RCM Inc. and Macy’s Inc., after a rough start to the year, with regulatory, legal and political hurdles delaying or outright quashing big deals.Most Read from BloombergLSE Joins Banks, Airlines in Cascade of Global DisruptionsCanada’s Immigration Minister Has a Message for Foreign Students: You Can’t All StayBrookfield Lines Up a 36-Year-Old Rising S Bloomberg • 6 days ago RCM -2.08% R1 RCM to Release Second Quarter 2024 Results on August 7, 2024 MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confer GlobeNewswire • 9 days ago RCM -2.08% New Mountain offers to acquire healthcare services provider R1 RCM New Mountain aims to purchase all of R1 RCM’s outstanding shares that it does not already own for $13.25 each. Hospital Management • 20 days ago RCM -2.08% Stocks to Watch Tuesday: Tesla, Chewy, Nvidia **↗️** **Tesla (TSLA)**: The electric-vehicle maker's shares rose roughly 9% after the company's second-quarter vehicle deliveries, a proxy for sales, fell by less than expected. Shares of smaller EV company **Rivian (RIVN)** also rallied. The Wall Street Journal • 22 days ago RCM -2.08% ERFSF TSLA R1 RCM to Host a Virtual Event “Technology Teach-In: A Deep Dive into Key Focus Areas and the R1 Platform” on June 27, 2024 MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. The event will feature Steve Albert, Executive Vice President and Chief Product Officer, and Brian Gambs, Executive Vice President and Chief Technolo GlobeNewswire • last month RCM -2.08% R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webc GlobeNewswire • last month RCM -2.08% R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Call Transcript R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Call Transcript May 8, 2024 R1 RCM Inc. misses on earnings expectations. Reported EPS is $-0.08349 EPS, expectations were $-0.05. R1 RCM Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […] Insider Monkey • 2 months ago RCM -2.08% R1 RCM Inc (RCM) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with Robust ... Despite facing operational disruptions, R1 RCM Inc (RCM) reports a strong financial performance and proactive crisis management in the first quarter of 2024. GuruFocus.com • 2 months ago RCM -2.08% Compared to Estimates, R1 RCM INC (RCM) Q1 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for R1 RCM INC (RCM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Zacks • 2 months ago RCM -2.08% R1 RCM Inc. (RCM) Q1 2024 Earnings: Revenue Surpasses Estimates Despite Net Loss Detailed Analysis of First Quarter Financials and Updated Outlook GuruFocus.com • 2 months ago RCM -2.08% R1 RCM Reports First Quarter 2024 Results MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss GlobeNewswire • 2 months ago RCM -2.08% R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Bank of America Securities Health Care Conference on Thursday, May 16, 2024, at 11:00am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay GlobeNewswire • 2 months ago RCM -2.08% 10 Best Healthcare Stocks to Buy Under $20 In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthcare Outlook for 2024 As 2024 progresses, the optimism surrounding the healthcare […] Insider Monkey • 3 months ago RCM -2.08% NVST +0.25% OSCR R1 RCM to Release First Quarter 2024 Results on May 8, 2024 MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confere GlobeNewswire • 3 months ago RCM -2.08% R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprintMURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company’s commitment to improving access to healthcare, bringing GlobeNewswire • 3 months ago RCM -2.08% R1 RCM Forms Special Committee to Evaluate Strategic Alternatives MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the GlobeNewswire • 4 months ago RCM -2.08% What Makes R1 RCM (RCM) a Lucrative Investment? Voss Capital, LLC an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned 19.4% and 18.6% net of fees and expenses respectively, in the fourth quarter compared to a 14.0% return for the […] Insider Monkey • 4 months ago RCM -2.08% ^RUT View Source13: R1 RCM 206,264 followers 1h Report this post Every day, we "Go Beyond" to make healthcare work better for all. Our team proactively considers client challenges, opportunities and solutions, actively seeks feedback for improvement, and consistently delivers exceptional outcomes. R1's leaders recognize the countless ways our associates live our values and create a workplace we are proud of. Meet some of R1’s global leaders and hear what they say about our Go Beyond value! #GoBeyond #Healthcare #Leadership #R1Values #CoreValues #RevenueCycle Lashana Jackson Vishal Desai Kristina Bourke Logan Johnston Andrea Gazis Jana Kopeinig Anderson Tony D'Ambrosio Roger Salazar Jr. …see more 21 Like Comment Share R1 RCM 206,264 followers 5h Report this post Want to learn the secret to increasing the success of clinical denials appeals with AI? Check out our latest article by Steven Albert, EVP, and Chief Product Officer at R1, to discover how AI can transform your claims management process and improve patient experiences. Click below to read the full article! #HealthcareInnovation #AIinHealthcare #RevenueCycleManagement #ClaimsDenials #PatientExperience #R1RCM Increase the Success of Clinical Denials Appeals With AI! R1 RCM on LinkedIn 41 Like Comment Share R1 RCM 206,264 followers 1w Report this post The rise in denials and payment delays from Medicare Advantage (MA) payers is causing significant financial and operational challenges for healthcare providers as these plans grow in popularity. How has your organization been impacted by these trends? Complete the poll below! #MedicareAdvantage #HealthcareChallenges #MedicalBilling #RevenueCycleManagement #HealthcareProviders #RevenueCycle This content isn’t available here Access this content and more in the LinkedIn app Download the app 37 1 Comment Like Comment Share R1 RCM 206,264 followers 1w Report this post Ever wondered how AI is reshaping healthcare? Healthcare organizations are realizing an impressive $3.20 return for every $1 invested in AI—imagine the possibilities! In her latest article, "Breaking the Iron Triangle with AI," Sarah Arvin, our Senior VP of Marketing and Communication, explores how AI accelerates clinical decisions, optimizes costs, and enhances patient care quality. Explore Sarah's in-depth insights into AI's transformative impact and envision the future of healthcare. https://ow.ly/eG8t50SCCKI #ArtificialIntelligence #HealthcareInnovation #AIinHealthcare #DigitalHealth #HealthTech 92 3 Comments Like Comment Share R1 RCM 206,264 followers 1w Report this post We had a great time at the 340B Coalition Summer Conference! Thank you to everyone who visited our Booth #713 and attended our sessions. Together, we're driving innovation and making healthcare work better for all! #340BConference #HealthcareInnovation #AI #Technology #340B #RCM 252 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post Ready to unlock hidden revenue and enhance efficiency with AI and Automation? Join our webinar 🗓️ July 24, 2024 | 12:00-12:45 PM EDT to dive into three practical uses of AI and automation that can revolutionize your revenue recovery. Register now and secure your spot! https://ow.ly/cNRw50SygBA Learn from industry experts how leading hospitals streamline coding, denial management, and more to boost cash flow. #HealthcareRevenueCycle #RevenueCycleManagement #HealthcareInnovation 42 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post At R1 RCM, we take ownership and pride in our work and make healthcare work better for all by committing to excellence and integrity in everything we do. This July, R1 Associates explore our Go Beyond value and put it to action by anticipating needs, asking for feedback, and seeing it through. Watch this video to learn more about our Go Beyond value! #GoBeyond #R1Values #CoreValues …see more 141 2 Comments Like Comment Share R1 RCM 206,264 followers 2w Edited Report this post Greetings from the 340B Coalition Summer Conference! Stop by, connect with our team, and let's drive healthcare forward together. ▪️ Visit Our Booth # 713 Grab a coffee and enter to win amazing prizes! ▪️ Lessons from the Field: Tuesday, July 9, at 7:15 AM Discover how to leverage technology and AI to optimize 340B referral capture. Click the link to learn how you can connect with us: https://ow.ly/3s0L50SxtxZ #340BConference #HealthcareInnovation #AI #Technology #ReferralCapture 340 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post As part of R1 RCM's continuous journey towards excellence, we are proud to introduce our three new core values: Partner with Purpose, Think Boldly, and Go Beyond. Today, John Lynch, our SVP Revenue Cycle Operations shares insights on what it means to Think Boldly in everything we do. Read on to learn how embracing bold thinking propels us to innovate and drive impactful change! #Innovation #CoreValues #ThinkBoldly #R1Values #RCM 184 Like Comment Share R1 RCM 206,264 followers 2w Report this post What an amazing #HFMAAnnual 2024 in Las Vegas! We enjoyed connecting and exchanging insights with industry peers and thought leaders. A big thank you to everyone who visited our lounge and joined our sessions. Click the link to explore how R1 RCM is transforming healthcare RCM: https://ow.ly/elrO50SuaYH #HFMA #RevenueCycle 811 14 Comments Like Comment Share View Source14: R1 RCM to Release Second Quarter 2024 Results on August 7, 2024 R1 RCM price target raised to $16 from $14 at Deutsche Bank Morgan Stanley thinks R1 RCM could reclaim 52-week high with TowerBrook bidding Stephens sees path to R1 RCM closing value gap with second bidder involved TCP-ASC says finalizing bid to acquire all outstanding R1 RCM shares not owned View Source15: PE firms mulling rival R1 RCM bid7 RCM headlines to know from MayR1 RCM allowing major shareholders to discuss buyout bid R1 RCM sees effects of Change cyberattack on Q1 results Availity taps R1 RCM exec as chief product officer View Source16: Richard Close has given his Buy rating due to a combination of factors surrounding R1 RCM’s business prospects and recent takeover interests. His valuation is premised on a 14.5 multiple applied to his projected 2024 adjusted EBITDA for R1 RCM, which reflects a 25% premium over peer group valuations. Close justifies this premium by pointing to R1 RCM’s comparatively higher margin profile. Furthermore, he acknowledges the ongoing challenges within the provider sector, such as reimbursement pressures and staffing issues, which he believes could increase demand for revenue cycle management services, thereby enhancing R1 RCM’s market position. Additionally, Close’s recommendation is reinforced by the recent developments involving TowerBrook and Ascension Health Alliance’s partnership with Clayton, Dubilier & Rice, which has led to a proposal to purchase R1 RCM shares at a value exceeding the previous offer by New Mountain Capital. The willingness of the R1 board to consider this new proposal suggests potential for a higher valuation, aligning with Close’s analysis. His expectations are further supported by the discussions around the return of former CEO Joseph Flanagan in a senior role following a potential privatization, which Close seems to view as a positive indicator for the company’s strategic direction. View Source17: George Hill has given his Hold rating due to a combination of factors related to the ongoing developments in R1 RCM’s acquisition scenario. Recent filings indicate TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) are considering a competing offer against New Mountain’s proposal to acquire R1 RCM. While a higher bid is anticipated, it remains uncertain, and any potential bid must outmatch the existing $13.25 per share offer from R1’s largest investor, New Mountain. This development has spurred a positive market reaction, but the final bid is expected to fall short of Hill’s $16 target price. Maintaining a cautious outlook, Hill acknowledges the possibility of a favorable bidding war elevating the stock price, yet he also recognizes the risks if the acquisition does not materialize. The current market valuation of R1 RCM appears to factor in the prospective transaction benefits, accounting for the time expected for deal closure. Moreover, Hill notes operational risks separate from the deal, such as the integration of Acclara and the onboarding of Providence. Despite the potential for R1 RCM to capitalize on long-term industry trends and internal growth opportunities, the near-term uncertainty surrounding both the acquisition and core business operations justifies the Hold rating. View Source18: MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to submit fully-financed bids on July 31, 2024 in connection with its review process. View Source19: R1 RCM Inc. is an American 'revenue cycle management' company servicing hospitals, health systems and physician groups across the United States.RCM is the process of managing all revenue-generation functions in a healthcare organization. It requires an understanding of the revenue cycle and begins when a patient seeks the organization's medical services and ends when the organization has collected all payments from the patient and/or their insurer. R1 has over 1,000 clients across the United States, including hospitals, health systems, and physician groups. R1 RCM employs more than 27,200 people and generates approximately $2.1 billion in annual revenue. View Source20: R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received. View Source21: R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives View Source22: Hold Rating Maintained Amid R1 RCM Acquisition Uncertainties and Market Reactions View Source23: R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL. View Source24: R1 RCM focus of rival takeover bid by TowerBrook, CD&R - report View Source25: The R1 RCM special committee has set a July 31 deadline for interested parties to submit fully-financed bids in connection with its review process. View Source26: All You Need to Know About R1 RCM View Source27: The analysis of recent analyst actions sheds light on the perception of R1 RCM by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. View Source28: Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of R1 RCM's market position. Stay informed and make well-informed decisions with our Ratings Table. View Source29: Revenue Growth: Over the 3 months period, R1 RCM showcased positive performance, achieving a revenue growth rate of 10.69% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector. View Source30: Net Margin: R1 RCM's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -5.81%, the company may face hurdles in effective cost management. View Source31: Return on Equity (ROE): R1 RCM's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -1.26%, the company showcases efficient use of equity capital and strong financial health. View Source32: Return on Assets (ROA): R1 RCM's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.65%, the company may encounter challenges in delivering satisfactory returns from its assets. View Source33: Debt Management: R1 RCM's debt-to-equity ratio is below the industry average at 0.85, reflecting a lower dependency on debt financing and a more conservative financial approach. View Source
R1 RCM Inc. is focused on expanding its technology-driven solutions to enhance the patient experience and financial performance of healthcare providers. For 2024 through 2026, the company aims to leverage artificial intelligence (AI) and automation to optimize revenue cycle management processes, as evidenced by their recent initiatives and webinars on AI applications in healthcare 34. Additionally, R1 RCM is actively exploring strategic alternatives, including potential acquisitions and partnerships, to strengthen its market position and drive growth 353637. The company is also committed to continuous improvement and innovation, as highlighted by its participation in industry conferences and the introduction of new core values to guide its operations 38.
34: R1 RCM 206,264 followers 1h Report this post Every day, we "Go Beyond" to make healthcare work better for all. Our team proactively considers client challenges, opportunities and solutions, actively seeks feedback for improvement, and consistently delivers exceptional outcomes. R1's leaders recognize the countless ways our associates live our values and create a workplace we are proud of. Meet some of R1’s global leaders and hear what they say about our Go Beyond value! #GoBeyond #Healthcare #Leadership #R1Values #CoreValues #RevenueCycle Lashana Jackson Vishal Desai Kristina Bourke Logan Johnston Andrea Gazis Jana Kopeinig Anderson Tony D'Ambrosio Roger Salazar Jr. …see more 21 Like Comment Share R1 RCM 206,264 followers 5h Report this post Want to learn the secret to increasing the success of clinical denials appeals with AI? Check out our latest article by Steven Albert, EVP, and Chief Product Officer at R1, to discover how AI can transform your claims management process and improve patient experiences. Click below to read the full article! #HealthcareInnovation #AIinHealthcare #RevenueCycleManagement #ClaimsDenials #PatientExperience #R1RCM Increase the Success of Clinical Denials Appeals With AI! R1 RCM on LinkedIn 41 Like Comment Share R1 RCM 206,264 followers 1w Report this post The rise in denials and payment delays from Medicare Advantage (MA) payers is causing significant financial and operational challenges for healthcare providers as these plans grow in popularity. How has your organization been impacted by these trends? Complete the poll below! #MedicareAdvantage #HealthcareChallenges #MedicalBilling #RevenueCycleManagement #HealthcareProviders #RevenueCycle This content isn’t available here Access this content and more in the LinkedIn app Download the app 37 1 Comment Like Comment Share R1 RCM 206,264 followers 1w Report this post Ever wondered how AI is reshaping healthcare? Healthcare organizations are realizing an impressive $3.20 return for every $1 invested in AI—imagine the possibilities! In her latest article, "Breaking the Iron Triangle with AI," Sarah Arvin, our Senior VP of Marketing and Communication, explores how AI accelerates clinical decisions, optimizes costs, and enhances patient care quality. Explore Sarah's in-depth insights into AI's transformative impact and envision the future of healthcare. https://ow.ly/eG8t50SCCKI #ArtificialIntelligence #HealthcareInnovation #AIinHealthcare #DigitalHealth #HealthTech 92 3 Comments Like Comment Share R1 RCM 206,264 followers 1w Report this post We had a great time at the 340B Coalition Summer Conference! Thank you to everyone who visited our Booth #713 and attended our sessions. Together, we're driving innovation and making healthcare work better for all! #340BConference #HealthcareInnovation #AI #Technology #340B #RCM 252 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post Ready to unlock hidden revenue and enhance efficiency with AI and Automation? Join our webinar 🗓️ July 24, 2024 | 12:00-12:45 PM EDT to dive into three practical uses of AI and automation that can revolutionize your revenue recovery. Register now and secure your spot! https://ow.ly/cNRw50SygBA Learn from industry experts how leading hospitals streamline coding, denial management, and more to boost cash flow. #HealthcareRevenueCycle #RevenueCycleManagement #HealthcareInnovation 42 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post At R1 RCM, we take ownership and pride in our work and make healthcare work better for all by committing to excellence and integrity in everything we do. This July, R1 Associates explore our Go Beyond value and put it to action by anticipating needs, asking for feedback, and seeing it through. Watch this video to learn more about our Go Beyond value! #GoBeyond #R1Values #CoreValues …see more 141 2 Comments Like Comment Share R1 RCM 206,264 followers 2w Edited Report this post Greetings from the 340B Coalition Summer Conference! Stop by, connect with our team, and let's drive healthcare forward together. ▪️ Visit Our Booth # 713 Grab a coffee and enter to win amazing prizes! ▪️ Lessons from the Field: Tuesday, July 9, at 7:15 AM Discover how to leverage technology and AI to optimize 340B referral capture. Click the link to learn how you can connect with us: https://ow.ly/3s0L50SxtxZ #340BConference #HealthcareInnovation #AI #Technology #ReferralCapture 340 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post As part of R1 RCM's continuous journey towards excellence, we are proud to introduce our three new core values: Partner with Purpose, Think Boldly, and Go Beyond. Today, John Lynch, our SVP Revenue Cycle Operations shares insights on what it means to Think Boldly in everything we do. Read on to learn how embracing bold thinking propels us to innovate and drive impactful change! #Innovation #CoreValues #ThinkBoldly #R1Values #RCM 184 Like Comment Share R1 RCM 206,264 followers 2w Report this post What an amazing #HFMAAnnual 2024 in Las Vegas! We enjoyed connecting and exchanging insights with industry peers and thought leaders. A big thank you to everyone who visited our lounge and joined our sessions. Click the link to explore how R1 RCM is transforming healthcare RCM: https://ow.ly/elrO50SuaYH #HFMA #RevenueCycle 811 14 Comments Like Comment Share View Source35: R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives Sets Final Bid Deadline of July 31, 2024MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested par GlobeNewswire • 10 hours ago RCM -2.08% TowerBrook, CD&R in Advanced Talks to Make Offer for Health IT Firm R1 RCM (Bloomberg) -- TowerBrook Capital Partners has teamed up with Clayton, Dubilier & Rice to make a joint offer for R1 RCM Inc. that could kick off a bidding war for the health-care IT company.Most Read from BloombergBiden Exits Race, Endorses Harris as She Shores Up SupportBiden Is Out: What’s Next for Democrats, ExplainedBiden’s Exit Puts Trump Trade in Doubt as Election Gets Re-SetTrump’s Remarks Spark Rebuke From Mexico’s President-ElectWho Gets the $96 Million Sitting in Biden’s Campaign Accou Bloomberg • 5 days ago RCM -2.08% TowerBrook, CD&R Consider Joining Forces to Bid for R1 RCM (Bloomberg) -- TowerBrook Capital Partners and Clayton, Dubilier & Rice are in talks to team up and launch a rival takeover bid for health-care IT provider R1 RCM Inc., people familiar with the matter said.Most Read from BloombergZuckerberg Calls Trump’s Response to Shooting ‘Badass’From ATMs to Flights, Epic IT Crash Leaves Trail of ChaosCrowdStrike’s Global Outage Doesn’t Have to Be a Recurring NightmareTravel Chaos Mounts as Airlines Resume Flights After OutageBiden Vows Return to Campaign Tr Bloomberg • 5 days ago RCM -2.08% Merger-Arb Traders Bet on a Few Deals After Ugly Start of Year (Bloomberg) -- Merger-arbitrage investors are betting on just a small handful of deals in the third quarter, including potential acquisitions of R1 RCM Inc. and Macy’s Inc., after a rough start to the year, with regulatory, legal and political hurdles delaying or outright quashing big deals.Most Read from BloombergLSE Joins Banks, Airlines in Cascade of Global DisruptionsCanada’s Immigration Minister Has a Message for Foreign Students: You Can’t All StayBrookfield Lines Up a 36-Year-Old Rising S Bloomberg • 6 days ago RCM -2.08% R1 RCM to Release Second Quarter 2024 Results on August 7, 2024 MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confer GlobeNewswire • 9 days ago RCM -2.08% New Mountain offers to acquire healthcare services provider R1 RCM New Mountain aims to purchase all of R1 RCM’s outstanding shares that it does not already own for $13.25 each. Hospital Management • 20 days ago RCM -2.08% Stocks to Watch Tuesday: Tesla, Chewy, Nvidia **↗️** **Tesla (TSLA)**: The electric-vehicle maker's shares rose roughly 9% after the company's second-quarter vehicle deliveries, a proxy for sales, fell by less than expected. Shares of smaller EV company **Rivian (RIVN)** also rallied. The Wall Street Journal • 22 days ago RCM -2.08% ERFSF TSLA R1 RCM to Host a Virtual Event “Technology Teach-In: A Deep Dive into Key Focus Areas and the R1 Platform” on June 27, 2024 MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. The event will feature Steve Albert, Executive Vice President and Chief Product Officer, and Brian Gambs, Executive Vice President and Chief Technolo GlobeNewswire • last month RCM -2.08% R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webc GlobeNewswire • last month RCM -2.08% R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Call Transcript R1 RCM Inc. (NASDAQ:RCM) Q1 2024 Earnings Call Transcript May 8, 2024 R1 RCM Inc. misses on earnings expectations. Reported EPS is $-0.08349 EPS, expectations were $-0.05. R1 RCM Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […] Insider Monkey • 2 months ago RCM -2.08% R1 RCM Inc (RCM) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with Robust ... Despite facing operational disruptions, R1 RCM Inc (RCM) reports a strong financial performance and proactive crisis management in the first quarter of 2024. GuruFocus.com • 2 months ago RCM -2.08% Compared to Estimates, R1 RCM INC (RCM) Q1 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for R1 RCM INC (RCM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Zacks • 2 months ago RCM -2.08% R1 RCM Inc. (RCM) Q1 2024 Earnings: Revenue Surpasses Estimates Despite Net Loss Detailed Analysis of First Quarter Financials and Updated Outlook GuruFocus.com • 2 months ago RCM -2.08% R1 RCM Reports First Quarter 2024 Results MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss GlobeNewswire • 2 months ago RCM -2.08% R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Bank of America Securities Health Care Conference on Thursday, May 16, 2024, at 11:00am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay GlobeNewswire • 2 months ago RCM -2.08% 10 Best Healthcare Stocks to Buy Under $20 In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthcare Outlook for 2024 As 2024 progresses, the optimism surrounding the healthcare […] Insider Monkey • 3 months ago RCM -2.08% NVST +0.25% OSCR R1 RCM to Release First Quarter 2024 Results on May 8, 2024 MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confere GlobeNewswire • 3 months ago RCM -2.08% R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprintMURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company’s commitment to improving access to healthcare, bringing GlobeNewswire • 3 months ago RCM -2.08% R1 RCM Forms Special Committee to Evaluate Strategic Alternatives MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the GlobeNewswire • 4 months ago RCM -2.08% What Makes R1 RCM (RCM) a Lucrative Investment? Voss Capital, LLC an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned 19.4% and 18.6% net of fees and expenses respectively, in the fourth quarter compared to a 14.0% return for the […] Insider Monkey • 4 months ago RCM -2.08% ^RUT View Source36: MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to submit fully-financed bids on July 31, 2024 in connection with its review process. View Source37: R1 RCM is controlled by funds affiliated with New Mountain Capital and TowerBrook through their collective ownership of Company stock representing 68% of the total voting power. On July 2, 2024, New Mountain Capital’s investment funds presented an acquisition proposal to the special committee of the board of directors of R1 RCM. The non-binding proposal seeks to acquire all the shares New Mountain Capital does not own for $13.25 per share, while inviting TowerBrook to rollover all or a portion of its stock into the post-close company. Should the special committee accept the proposal, minority shareholders will be cashed out and deprived of any future upside in the private company. View Source38: R1 RCM 206,264 followers 1h Report this post Every day, we "Go Beyond" to make healthcare work better for all. Our team proactively considers client challenges, opportunities and solutions, actively seeks feedback for improvement, and consistently delivers exceptional outcomes. R1's leaders recognize the countless ways our associates live our values and create a workplace we are proud of. Meet some of R1’s global leaders and hear what they say about our Go Beyond value! #GoBeyond #Healthcare #Leadership #R1Values #CoreValues #RevenueCycle Lashana Jackson Vishal Desai Kristina Bourke Logan Johnston Andrea Gazis Jana Kopeinig Anderson Tony D'Ambrosio Roger Salazar Jr. …see more 21 Like Comment Share R1 RCM 206,264 followers 5h Report this post Want to learn the secret to increasing the success of clinical denials appeals with AI? Check out our latest article by Steven Albert, EVP, and Chief Product Officer at R1, to discover how AI can transform your claims management process and improve patient experiences. Click below to read the full article! #HealthcareInnovation #AIinHealthcare #RevenueCycleManagement #ClaimsDenials #PatientExperience #R1RCM Increase the Success of Clinical Denials Appeals With AI! R1 RCM on LinkedIn 41 Like Comment Share R1 RCM 206,264 followers 1w Report this post The rise in denials and payment delays from Medicare Advantage (MA) payers is causing significant financial and operational challenges for healthcare providers as these plans grow in popularity. How has your organization been impacted by these trends? Complete the poll below! #MedicareAdvantage #HealthcareChallenges #MedicalBilling #RevenueCycleManagement #HealthcareProviders #RevenueCycle This content isn’t available here Access this content and more in the LinkedIn app Download the app 37 1 Comment Like Comment Share R1 RCM 206,264 followers 1w Report this post Ever wondered how AI is reshaping healthcare? Healthcare organizations are realizing an impressive $3.20 return for every $1 invested in AI—imagine the possibilities! In her latest article, "Breaking the Iron Triangle with AI," Sarah Arvin, our Senior VP of Marketing and Communication, explores how AI accelerates clinical decisions, optimizes costs, and enhances patient care quality. Explore Sarah's in-depth insights into AI's transformative impact and envision the future of healthcare. https://ow.ly/eG8t50SCCKI #ArtificialIntelligence #HealthcareInnovation #AIinHealthcare #DigitalHealth #HealthTech 92 3 Comments Like Comment Share R1 RCM 206,264 followers 1w Report this post We had a great time at the 340B Coalition Summer Conference! Thank you to everyone who visited our Booth #713 and attended our sessions. Together, we're driving innovation and making healthcare work better for all! #340BConference #HealthcareInnovation #AI #Technology #340B #RCM 252 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post Ready to unlock hidden revenue and enhance efficiency with AI and Automation? Join our webinar 🗓️ July 24, 2024 | 12:00-12:45 PM EDT to dive into three practical uses of AI and automation that can revolutionize your revenue recovery. Register now and secure your spot! https://ow.ly/cNRw50SygBA Learn from industry experts how leading hospitals streamline coding, denial management, and more to boost cash flow. #HealthcareRevenueCycle #RevenueCycleManagement #HealthcareInnovation 42 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post At R1 RCM, we take ownership and pride in our work and make healthcare work better for all by committing to excellence and integrity in everything we do. This July, R1 Associates explore our Go Beyond value and put it to action by anticipating needs, asking for feedback, and seeing it through. Watch this video to learn more about our Go Beyond value! #GoBeyond #R1Values #CoreValues …see more 141 2 Comments Like Comment Share R1 RCM 206,264 followers 2w Edited Report this post Greetings from the 340B Coalition Summer Conference! Stop by, connect with our team, and let's drive healthcare forward together. ▪️ Visit Our Booth # 713 Grab a coffee and enter to win amazing prizes! ▪️ Lessons from the Field: Tuesday, July 9, at 7:15 AM Discover how to leverage technology and AI to optimize 340B referral capture. Click the link to learn how you can connect with us: https://ow.ly/3s0L50SxtxZ #340BConference #HealthcareInnovation #AI #Technology #ReferralCapture 340 1 Comment Like Comment Share R1 RCM 206,264 followers 2w Report this post As part of R1 RCM's continuous journey towards excellence, we are proud to introduce our three new core values: Partner with Purpose, Think Boldly, and Go Beyond. Today, John Lynch, our SVP Revenue Cycle Operations shares insights on what it means to Think Boldly in everything we do. Read on to learn how embracing bold thinking propels us to innovate and drive impactful change! #Innovation #CoreValues #ThinkBoldly #R1Values #RCM 184 Like Comment Share R1 RCM 206,264 followers 2w Report this post What an amazing #HFMAAnnual 2024 in Las Vegas! We enjoyed connecting and exchanging insights with industry peers and thought leaders. A big thank you to everyone who visited our lounge and joined our sessions. Click the link to explore how R1 RCM is transforming healthcare RCM: https://ow.ly/elrO50SuaYH #HFMA #RevenueCycle 811 14 Comments Like Comment Share View Source